Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis.
about
Rifaximin for maintenance therapy in antibiotic-dependent pouchitisSurgical Principles in the Treatment of Ulcerative ColitisCurrent status and prospects of intestinal microbiome studiesUse of Biologics in Pouchitis: A Systematic ReviewThe role of antibiotics and probiotics in pouchitisBacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis.Rapid determination of rifaximin on dried blood spots by LC-ESI-MS.Antibiotics and probiotics in treatment of inflammatory bowel disease.Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice.Pouchitis.Diagnosis and management of postoperative ileal pouch disorders.Rifaximin, a poorly absorbed antibiotic: pharmacology and clinical potential.Absence of effect of oral rifaximin on the pharmacokinetics of ethinyl estradiol/norgestimate in healthy females.The effect of multiple-dose, oral rifaximin on the pharmacokinetics of intravenous and oral midazolam in healthy volunteers.Comparative transcription analysis and toxin production of two fluoroquinolone-resistant mutants of Clostridium perfringensReview article: treatment of mild to moderate ulcerative colitis and pouchitis.The role of the gut flora in health and disease, and its modification as therapy.Association between specific mucosa-associated microbiota in Crohn's disease at the time of resection and subsequent disease recurrence: a pilot study.Engineering the Microbiome: a Novel Approach to Immunotherapy for Allergic and Immune Diseases.Variable alterations of the microbiota, without metabolic or immunological change, following faecal microbiota transplantation in patients with chronic pouchitisManagement of inflammatory bowel disease: does rifaximin offer any promise?Rifaximin: a nonabsorbable rifamycin antibiotic for use in nonsystemic gastrointestinal infections.Maintenance therapy with a probiotic in antibiotic-dependent pouchitis: experience in clinical practice.Clinical approach to diseases of ileal pouch-anal anastomosis.Experimental and clinical pharmacology of rifaximin, a gastrointestinal selective antibiotic.Antimicrobials in the management of inflammatory bowel disease.Systematic review: the management of pouchitis.Comparative efficacies of rifaximin and vancomycin for treatment of Clostridium difficile-associated diarrhea and prevention of disease recurrence in hamsters.Systemic pharmacokinetics of rifaximin in volunteers with shigellosis.Use of antibiotics in the treatment of inflammatory bowel disease.Rifaximin: a unique gastrointestinal-selective antibiotic for enteric diseasesPros and cons of antibiotic therapy for pouchitis.Utility of the Nonabsorbed (<0.4%) Antibiotic Rifaximin in Gastroenterology and Hepatology.Rifaximin: a nonsystemic rifamycin antibiotic for gastrointestinal infections.Surgical prophylaxis of pouchitis in ulcerative colitis.Characterization of the gastrointestinal microbiota in health and inflammatory bowel disease.Transmural inflammation is not pathognomonic for Crohn's disease of the pouch.Optimization of conventional therapy in patients with IBD.Etiology of pouchitis.Acute and chronic pouchitis--pathogenesis, diagnosis and treatment.
P2860
Q21261868-FD1A142D-2F0A-4897-99E1-1B8D6C5CDAB9Q26777727-6071B526-B1D8-443B-9F9E-049E862A7F12Q26851992-C56B1E0C-F112-4E03-BF67-0F1508BDE93DQ26995117-B21C0757-AF50-4D30-B085-768FFE4857FFQ27000314-53ADCAF1-9092-4CAF-A68D-88CEE4B2DBB4Q33231186-98B6A9C0-4F77-47A7-9272-8FDB15FED90AQ33810436-F99D868C-0AEA-4A29-9783-EC0EAA13D191Q33867934-D11650EE-9EF5-498F-8D5B-1F3CF587E56EQ34006798-079DA0B0-BEAB-43C2-B184-8628C755AA0FQ34233134-A9264210-2E17-4075-8C94-60CA1603A7B9Q34237313-32B9C620-8044-4885-94F9-67CF4FF53A69Q34557101-23841FB7-6CD3-4594-B5A7-67C1D6AD7873Q34574939-E3FB2C1F-1EB8-4A55-B91C-D1055D4326EFQ34583322-F8CF8F0A-DBD6-418A-800D-632640C22691Q34604406-3CB0EFFF-C078-49D8-907A-046407525EECQ34669202-BD82059E-4896-447C-8C74-03ECC455F314Q34786696-065FDA92-203C-44B2-90C0-7D6D90EE1930Q35217975-175092B7-92C7-41A1-85EC-AEC05A73EFFAQ35682862-9D43FA40-0F08-4E26-A7B3-697A2854C294Q35942223-21F12269-7346-4E55-8E42-1A89F9574D52Q36108499-41D9A227-D922-4F21-8559-CC17BD00F4A6Q36140657-F4E8A2F9-BBC4-4EBD-AB24-B86FEF264EBCQ36273531-8FF713E0-FA96-44D8-B221-F2633CCF298AQ36360514-F5F95D91-8944-45EC-8F8D-CCEB9E7A8571Q36404922-24E5DC63-138D-4AEA-9597-E57BB96DE30AQ36404946-EBC4B89A-2261-4962-B254-4E7004E32637Q36447568-0EFAE672-B809-4788-BD88-4D4F04EFF788Q36482832-152D731C-3C9A-413C-9202-80D372CC4D20Q36482910-A66CE2CB-F41B-489B-B77C-2BC318A36DC1Q36521201-AF465763-2241-471B-8403-B29125E42D67Q36533648-685C854A-E068-4CD7-8696-0DC56525BF59Q37611860-25A64CFE-C6D7-4565-B4E9-FFE0C5F79D6AQ37678916-DF8A7651-7324-43DE-A9DE-AA8A6CC52E7BQ37768415-8F737AE4-583B-4EF9-BF8A-644F581DA94BQ37815426-479ABCDA-AF77-432F-93F5-F2E60DF70A40Q37878446-7167837F-E091-4CAF-BCEA-445A1F8AF040Q37887577-6372DD64-6EF5-44A0-9401-B62A2D94C592Q37942292-1FC49278-B96D-41B1-87E5-4FA7DAAE9CBCQ37948714-7FB3AD0F-6B69-4054-8BC8-50F3D7D92403Q38003046-287EA8F5-0D10-4ED8-933C-B80186F738EE
P2860
Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis.
@ast
Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis.
@en
Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis.
@nl
type
label
Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis.
@ast
Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis.
@en
Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis.
@nl
prefLabel
Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis.
@ast
Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis.
@en
Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis.
@nl
P2093
P2860
P50
P1476
Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis
@en
P2093
P2860
P304
P356
10.1046/J.1365-2036.1999.00553.X
P407
P577
1999-06-01T00:00:00Z